Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04659759 · ClinicalTrials.gov registry record
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 105
- Enrollment target
NCT04659759 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 105 participants.
The verdict
NCT04659759 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
This is a prospective cohort study of pregnant patients at an urban academic center diagnosed with perinatal COVID-19 infection, followed up to 6 weeks postpartum.
Interventions
- BIOLOGICAL COVID-19 vaccine
- OTHER COVID-19 exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2020-11-17 |
| Est. Completion | 2025-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04659759
The ClinicalTrials.gov registry entry for NCT04659759 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which COVID-19 vaccine is the first listed.
NCT04659759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04659759 about?
NCT04659759 is a clinical study titled "COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes". This is a prospective cohort study of pregnant patients at an urban academic center diagnosed with perinatal COVID-19 infection, followed up to 6 weeks postpartum.
What is the current status of trial NCT04659759?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2020-11-17. Estimated completion is 2025-08-30.
What interventions are being tested in trial NCT04659759?
The interventions under investigation include: COVID-19 vaccine (BIOLOGICAL), COVID-19 exposure (OTHER).
Who is sponsoring clinical trial NCT04659759?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.